Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study

Background: In heavily pretreated patients with metastatic triple-negative breast cancer (mTNBC), further systemic therapy offers limited benefit and increased toxicity. Recognizing the end-of-life (EOL) phase in time helps avoid overtreatment and ensure goal-concordant care. This study analyzed the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Justyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Lenka Rušinová, Renáta Soumarová, Hana Študentová, Aleksandra Konieczna, Agnieszka Młodzińska, Karolina Winsko-Szczęsnowicz, Maja Lisik-Habib, Anika Pękala, Daniel Krejčí, Jan Šustr, Iveta Kolářová, Iwona Danielewicz, Magdalena Szymanik-Resko, Tomasz Ciszewski, Miloš Holánek, Bogumiła Czartoryska-Arłukowicz, Aleksandra Łacko, Jolanta Smok-Kalwat, Michał Jarząb, Renata Pacholczak-Madej, Iwona Ługowska, Zuzana Bielčiková, Miroslava Malejčíková, Mirosława Püsküllüoğlu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-02-01
coleção:	Breast
Assuntos:	Triple negative breast cancer Palliative systemic therapy Palliative care integration End-of-life care Real-world data
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S0960977626000093
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!